Impact of immunosuppressive treatment on the immunogenicity of mRNA COVID-19 vaccine in vulnerable patients with giant cell arteritis-Reference-Cited by-同舟云学术

Impact of immunosuppressive treatment on the immunogenicity of mRNA COVID-19 vaccine in vulnerable patients with giant cell arteritis

Published:2021-10-19 Issue:2 Volume:61 Page:870-872
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Delvino Paolo¹²^ORCID,Bartoletti Alice¹,Cassaniti Irene³⁴,Bergami Federica³,Lilleri Daniele³⁴,Baldanti Fausto³⁴,Bozzalla Cassione Emanuele¹,Biglia Alessandro¹,Montecucco Carlomaurizio¹,Monti Sara¹^ORCID

Affiliation:

1. Rheumatology Department, IRCCS Policlinico San Matteo Foundation

2. PhD in Experimental Medicine, University of Pavia

3. Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo

4. Department of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy

Funder

Ministero della Salute, Ricerca Corrente

Ricerca Finalizzata

Commission—Horizon 2020 (EU

Fondazione Cariplo

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keab776/40840322/keab776.pdf

Reference5 articles.

1. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study;Furer;Ann Rheum Dis,2021

2. Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease;Haberman;Ann Rheum Dis.,2021

3. Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases;Boyarsky;Ann Rheum Dis,2021

4. Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis;Bugatti;Ann Rheum Dis,2021

5. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Three Cases of Arteritic Anterior Optic Neuropathy Several Months after COVID-19 Vaccination;Case Reports in Ophthalmological Medicine;2023-09-11

2. Humoral SARS–CoV‐2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the Booster;Arthritis Care & Research;2023-08-04

3. Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019;Rheumatic Disease Clinics of North America;2023-08

4. Effect of DMARDs on the immunogenicity of vaccines;Nature Reviews Rheumatology;2023-07-12

5. Increased incidence of giant cell arteritis and associated stroke during the COVID-19 pandemic in Spain: A nation-wide population study;Autoimmunity Reviews;2023-06